173 related articles for article (PubMed ID: 1466313)
21. [Prevalence of dyslipidemia among residents aged 18-69 years in Shandong province of China, 2011].
Zhang J; Tang J; Guo X; Dong J; Ren J; Chen X; Gao C; Xu A
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Mar; 50(3):230-4. PubMed ID: 26957240
[TBL] [Abstract][Full Text] [Related]
22. Two different views of the relationship of hypertriglyceridemia to coronary heart disease. Implications for treatment.
Grundy SM; Vega GL
Arch Intern Med; 1992 Jan; 152(1):28-34. PubMed ID: 1728925
[TBL] [Abstract][Full Text] [Related]
23. Rationale and design of the Department of Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial (HIT) for secondary prevention of coronary artery disease in men with low high-density lipoprotein cholesterol and desirable low-density lipoprotein cholesterol.
Rubins HB; Robins SJ; Iwane MK; Boden WE; Elam MB; Fye CL; Gordon DJ; Schaefer EJ; Schectman G; Wittes JT
Am J Cardiol; 1993 Jan; 71(1):45-52. PubMed ID: 8420235
[TBL] [Abstract][Full Text] [Related]
24. Enhanced cellular uptake of remnant high-density lipoprotein particles: a mechanism for high-density lipoprotein lowering in insulin resistance and hypertriglyceridemia.
Xiao C; Watanabe T; Zhang Y; Trigatti B; Szeto L; Connelly PW; Marcovina S; Vaisar T; Heinecke JW; Lewis GF
Circ Res; 2008 Jul; 103(2):159-66. PubMed ID: 18556574
[TBL] [Abstract][Full Text] [Related]
25. Mode of action of fibrates in the regulation of triglyceride and HDL-cholesterol metabolism.
Fruchart JC; Duriez P
Drugs Today (Barc); 2006 Jan; 42(1):39-64. PubMed ID: 16511610
[TBL] [Abstract][Full Text] [Related]
26. Hypertriglyceridemia as a cardiovascular risk factor.
Austin MA; Hokanson JE; Edwards KL
Am J Cardiol; 1998 Feb; 81(4A):7B-12B. PubMed ID: 9526807
[TBL] [Abstract][Full Text] [Related]
27. Relationship of triglycerides and HDL cholesterol in hypertriglyceridemia.
Avogaro P; Ghiselli G; Soldan S; Bittolo Bon G
Atherosclerosis; 1992 Jan; 92(1):79-86. PubMed ID: 1575823
[TBL] [Abstract][Full Text] [Related]
28. Hypertriglyceridemia as a possible independent risk factor for stroke.
Lisak M; Demarin V; Trkanjec Z; Basić-Kes V
Acta Clin Croat; 2013 Dec; 52(4):458-63. PubMed ID: 24696996
[TBL] [Abstract][Full Text] [Related]
29. Hypertriglyceridemia and low HDL: therapeutic considerations.
Larsen ML
Curr Opin Lipidol; 1994 Feb; 5(1):42-7. PubMed ID: 15559030
[TBL] [Abstract][Full Text] [Related]
30. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
[TBL] [Abstract][Full Text] [Related]
31. [High triglyceride, low HDL-cholesterol and risk of coronary heart disease].
Jeppesen J; Madsbad S
Ugeskr Laeger; 1996 Nov; 158(48):6896-901. PubMed ID: 8984751
[TBL] [Abstract][Full Text] [Related]
32. Plasma triglyceride as a risk factor for coronary heart disease. The epidemiologic evidence and beyond.
Austin MA
Am J Epidemiol; 1989 Feb; 129(2):249-59. PubMed ID: 2643302
[TBL] [Abstract][Full Text] [Related]
33. Hypertriglyceridemia and low HDL cholesterol in Japanese patients with NIDDM.
Okubo M; Murase T
Diabetes; 1996 Jul; 45 Suppl 3():S123-5. PubMed ID: 8674878
[TBL] [Abstract][Full Text] [Related]
34. [Increased triglycerides and/or low HDL cholesterol. A risk factor needing treatment?].
Steinmetz A
MMW Fortschr Med; 2002 Aug; 144(31-32):20-3. PubMed ID: 12422724
[TBL] [Abstract][Full Text] [Related]
35. [Serum triglycerides as a risk factor for atherosclerosis].
Stalenhoef AF
Ned Tijdschr Geneeskd; 1999 Feb; 143(6):284-7. PubMed ID: 10221081
[TBL] [Abstract][Full Text] [Related]
36. Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology.
Nordestgaard BG
Circ Res; 2016 Feb; 118(4):547-63. PubMed ID: 26892957
[TBL] [Abstract][Full Text] [Related]
37. Low high-density lipoprotein cholesterol and other coronary heart disease risk factors in patients with total cholesterol levels greater than 5.17 mmol/L (200 mg/dL) in family practice. A report from CEN.
J Am Board Fam Pract; 1991; 4(5):285-97. PubMed ID: 1746296
[TBL] [Abstract][Full Text] [Related]
38. Non-HDL cholesterol as a measure of atherosclerotic risk.
Packard CJ; Saito Y
J Atheroscler Thromb; 2004; 11(1):6-14. PubMed ID: 15067193
[TBL] [Abstract][Full Text] [Related]
39. Management of dyslipidemia in the metabolic syndrome: recommendations of the Spanish HDL-Forum.
Ascaso J; Gonzalez Santos P; Hernandez Mijares A; Mangas Rojas A; Masana L; Millan J; Pallardo LF; Pedro-Botet J; Perez Jimenez F; Pintó X; Plaza I; Rubiés J; Zúñiga M
Am J Cardiovasc Drugs; 2007; 7(1):39-58. PubMed ID: 17355165
[TBL] [Abstract][Full Text] [Related]
40. Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS).
Saito Y; Yokoyama M; Origasa H; Matsuzaki M; Matsuzawa Y; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K;
Atherosclerosis; 2008 Sep; 200(1):135-40. PubMed ID: 18667204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]